title: Fertility of ejaculated and testicular megalohead spermatozoa with intracytoplasmic sperm injection.
abstract: In this study the fertility and outcome of intracytoplasmic sperm injection (ICSI) using megalohead spermatozoa from the ejaculates and testicles was evaluated. Seventeen males with megalohead and pinhead sperm forms in their ejaculate were studied in 22 cycles. A high number of sperm heads without tails and abundant round spermatid forms were commonly observed. Round-headed spermatozoa were seldom accompanied by these severely abnormal spermatozoa. The majority of megalohead spermatozoa were observed to have multiple tails, were predominant in the sample, and were used for ICSI. Ejaculated megalohead spermatozoa were used for ICSI in 15 cycles, while testicular spermatozoa were used in seven cycles where there were no vital spermatozoa or spermatozoa of low vitality in the ejaculate. The same abnormal morphology was observed in the testicles as in the ejaculated spermatozoa in the same males. Mean (+/- SD) low motility 4.7 +/- 5.6% and sperm count (3.8 +/- 4.19 x 10(6)) were common findings in these severely teratozoospermic patients. A low fertilization rate (43.2%) was achieved by using megalohead sperm forms (group I, n = 17) in comparison with the control group (60.2%) which had zero normal sperm morphology according to strict criteria (group II, n = 30) (P <0.01). Furthermore, a low pregnancy rate (9.1%) was obtained in the megalohead sperm group in comparison with the control group (40%) (P <0.05). Low fertilization and pregnancy rates may be due to a high incidence of chromosomal abnormalities from severely defective spermatozoa in the ejaculate. Couples should be counselled and warned about possible low fertilization and pregnancy rates with ICSI when only pinhead and megalohead forms with a high number of sperm heads without tails are present in the ejaculate.
authors.affiliation: Sevgi Hospital, Assisted Reproductive Techniques and Reproductive Endocrinology Unit, Ankara, Turkey.
authors.forename: S
authors.initials: S
authors.lastname: Kahraman
authors.forename: C
authors.initials: C
authors.lastname: Akarsu
authors.forename: G
authors.initials: G
authors.lastname: Cengiz
authors.forename: K
authors.initials: K
authors.lastname: Dirican
authors.forename: E
authors.initials: E
authors.lastname: Sözen
authors.forename: B
authors.initials: B
authors.lastname: Can
authors.forename: C
authors.initials: C
authors.lastname: Güven
authors.forename: P
authors.initials: P
authors.lastname: Vanderzwalmen
mesh_terms: D000328:Adult; D004542:Ejaculation; D004624:Embryo Transfer; D005260:Female; D005307:Fertilization in Vitro / Q000379:methods*; D006801:Humans; D007248:Infertility, Male / Q000628:therapy*; D008297:Male; D008845:Microinjections; D010062:Ovulation Induction; D011247:Pregnancy; D013077:Sperm Head; D013082:Sperm Tail; D013094:Spermatozoa / Q000002:abnormalities*; D013737:Testis / Q000166:cytology*; D016896:Treatment Outcome